Published in Med Clin (Barc) on February 16, 2008
Statistical reviewers improve reporting in biomedical articles: a randomized trial. PLoS One (2007) 1.49
Outcome after relapse of acute lymphoblastic leukemia in adult patients included in four consecutive risk-adapted trials by the PETHEMA Study Group. Haematologica (2010) 1.44
Frequency of ABL gene mutations in chronic myeloid leukemia patients resistant to imatinib and results of treatment switch to second-generation tyrosine kinase inhibitors. Med Clin (Barc) (2013) 1.38
High-dose chemotherapy and immunotherapy in adult Burkitt lymphoma: comparison of results in human immunodeficiency virus-infected and noninfected patients. Cancer (2008) 1.30
Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patients. Blood (2013) 1.13
Results of treatment with doxorubicin, bleomycin, vinblastine and dacarbazine and highly active antiretroviral therapy in advanced stage, human immunodeficiency virus-related Hodgkin's lymphoma. Haematologica (2007) 1.10
Outcome according to cytogenetic abnormalities and DNA ploidy in myeloma patients receiving short induction with weekly bortezomib followed by maintenance. Blood (2011) 1.03
The prognosis of HIV-infected patients with diffuse large B-cell lymphoma treated with chemotherapy and highly active antiretroviral therapy is similar to that of HIV-negative patients receiving chemotherapy. Haematologica (2005) 1.02
Immunohistochemical detection of MYC protein correlates with MYC gene status in aggressive B cell lymphomas. Histopathology (2011) 1.01
Safety and efficacy of cyclophosphamide, adriamycin, vincristine, prednisone and rituximab in patients with human immunodeficiency virus-associated diffuse large B-cell lymphoma: results of a phase II trial. Br J Haematol (2007) 1.00
Hepatosplenic T-gammadelta lymphoma in a patient with Crohn's disease treated with azathioprine. Leuk Lymphoma (2003) 0.97
Prognostic factors in patients with HIV-associated peripheral T-cell lymphoma: a multicenter study. Am J Hematol (2011) 0.95
Highly active antiretroviral therapy and outcome of AIDS-related Burkitt's lymphoma or leukemia. Results of the PETHEMA-LAL3/97 study. Haematologica (2005) 0.94
Predictive factors for poor peripheral blood stem cell mobilization and peak CD34(+) cell count to guide pre-emptive or immediate rescue mobilization. Cytotherapy (2012) 0.92
Homocysteine, C-reactive protein, lipid peroxidation and mortality in haemodialysis patients. Nephrol Dial Transplant (2003) 0.91
Usefulness of tumor markers CA 125 and CA 15.3 at diagnosis and during follow-up in non-Hodgkin's lymphoma: study of 200 patients. Leuk Lymphoma (2005) 0.89
Outcome and prognostic factors in patients with hematologic malignancies admitted to the intensive care unit: a single-center experience. Int J Hematol (2007) 0.89
Compassionate use of intrathecal depot liposomal cytarabine as treatment of central nervous system involvement in acute leukemia: report of 6 cases. Haematologica (2006) 0.89
Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia. Eur J Haematol (2006) 0.88
Translocation (3;8)(q27;q24) in two cases of triple hit lymphoma. Cancer Genet Cytogenet (2010) 0.88
Monosomy 7 with severe myelodysplasia developing during imatinib treatment of Philadelphia-positive chronic myeloid leukemia: two cases with a different outcome. Am J Hematol (2007) 0.88
Clinical significance of occult cerebrospinal fluid involvement assessed by flow cytometry in non-Hodgkin's lymphoma patients at high risk of central nervous system disease in the rituximab era. Eur J Haematol (2010) 0.88
Allogeneic stem cell transplantation for adult acute lymphoblastic leukemia: when and how. Haematologica (2011) 0.87
Lack of influence of human immunodeficiency virus infection status in the response to therapy and survival of adult patients with mature B-cell lymphoma or leukemia. Results of the PETHEMA-LAL3/97 study. Haematologica (2003) 0.87
Central nervous system recurrence in adult patients with acute lymphoblastic leukemia: frequency and prognosis in 467 patients without cranial irradiation for prophylaxis. Cancer (2006) 0.87
Usefulness and safety of oral cryotherapy in the prevention of oral mucositis after conditioning regimens with high-dose melphalan for autologous stem cell transplantation for lymphoma and myeloma. Eur J Haematol (2014) 0.86
Human immunodeficiency virus-related non-Hodgkin's lymphoma. Haematologica (2008) 0.86
Oral solid form of primary effusion lymphoma mimicking plasmablastic lymphoma. Hum Pathol (2004) 0.85
Results of compassionate therapy with intrathecal depot liposomal cytarabine in acute myeloid leukemia meningeosis. Int J Hematol (2007) 0.85
Long-term follow-up of patients with HIV-related diffuse large B-cell lymphomas treated in a phase II study with rituximab and CHOP. Br J Haematol (2012) 0.85
Unrelated transplantation for poor-prognosis adult acute lymphoblastic leukemia: long-term outcome analysis and study of the impact of hematopoietic graft source. Biol Blood Marrow Transplant (2010) 0.85
Decrease in the frequency of meningeal involvement in AIDS-related systemic lymphoma in patients receiving HAART. Haematologica (2008) 0.84
Results of treatment with azacitidine in patients aged ≥ 75 years included in the Spanish Registry of Myelodysplastic Syndromes. Leuk Lymphoma (2013) 0.83
Improved outcome of AIDS-related lymphoma in patients with virologic response to highly active antiretroviral therapy. J Acquir Immune Defic Syndr (2003) 0.82
In vivo quantification of response to treatment in patients with multiple myeloma by 1H magnetic resonance spectroscopy of bone marrow. MAGMA (2007) 0.81
Limited prognostic value of the International Prognostic Score in advanced stage human immunodeficiency virus infection-related Hodgkin lymphoma treated with the doxorubicin, bleomycin, vinblastine, and dacarbazine regimen. Leuk Lymphoma (2009) 0.81
Dose-intensive chemotherapy including rituximab is highly effective but toxic in human immunodeficiency virus-infected patients with Burkitt lymphoma/leukemia: parallel study of 81 patients. Leuk Lymphoma (2014) 0.81
Practice of central nervous system prophylaxis and treatment in acute leukemias in Spain. Prospective registry study. Med Clin (Barc) (2008) 0.80
Anorectal lymphoma without effusion associated with human herpesvirus-8 and type 1 Epstein-Barr virus in an HIV-infected patient. Hum Pathol (2003) 0.79
Immunohistochemical expression profile and prognosis in patients with diffuse large B-cell lymphoma with or without human immunodeficiency virus infection. Leuk Lymphoma (2010) 0.79
Usefulness of IGH/TCR PCR studies in lymphoproliferative disorders with inconclusive clonality by flow cytometry. Cytometry B Clin Cytom (2013) 0.79
Systemic lupus erythematosus in a patient with primary MALT lymphoma of the larynx. Ear Nose Throat J (2009) 0.79
Long-term follow up of patients with human immunodeficiency virus infection and advanced stage Hodgkin's lymphoma treated with doxorubicin, bleomycin, vinblastine and dacarbazine. Haematologica (2013) 0.78
Feasibility and results of autologous stem cell transplantation in de novo acute myeloid leukemia in patients over 60 years old. Results of the CETLAM AML-99 protocol. Haematologica (2004) 0.78
Correlation of CD11b and CD56 expression in adult acute myeloid leukemia with cytogenetic risk groups and prognosis. Ann Hematol (2014) 0.78
Oral induction and consolidation chemotherapy with idarubicin and etoposide in elderly patients with acute myeloid leukemia. Haematologica (2003) 0.78
[Alveolar haemorrhage and HELLP syndrome]. Med Clin (Barc) (2007) 0.78
Immunophenotypic findings in acute myeloid leukemia with FLT3 internal tandem duplication. Haematologica (2003) 0.77
Contribution of cerebrospinal fluid sCD19 levels to the detection of CNS lymphoma and its impact on disease outcome. Blood (2014) 0.77
[Sustained remission in an adult patient with Langerhans cell histiocytosis following T-cell depleted allogenic cell transplantation]. Med Clin (Barc) (2006) 0.77
[Thrombotic thrombocytopenic purpura during treatment with interpheron]. Med Clin (Barc) (2007) 0.77
Outcome of graft failure after allogeneic stem cell transplant: study of 89 patients. Leuk Lymphoma (2014) 0.76
Prospective study on the practice of central nervous system prophylaxis and treatment in non-Hodgkin's lymphoma in Spain. Med Clin (Barc) (2008) 0.76
[Osteoporosis as a first manifestation of systemic mastocytosis. Study of 6 cases]. Med Clin (Barc) (2007) 0.76
Plasma Epstein-Barr viral load measurement as a diagnostic marker of lymphoma in HIV-infected patients. Med Clin (Barc) (2010) 0.76
Lack of impact of human immunodeficiency virus infection on the outcome of lymphoma patients transferred to the intensive care unit. Leuk Lymphoma (2012) 0.76
Serum pepsinogen I: an early marker of pernicious anemia in patients with type 1 diabetes. J Clin Endocrinol Metab (2005) 0.76
Successful response to rituximab in a patient with pure red cell aplasia complicating chronic lymphocytic leukaemia. Br J Haematol (2002) 0.76
Prognostic significance of complex karyotype and monosomal karyotype in adult patients with acute lymphoblastic leukemia treated with risk-adapted protocols. Cancer (2014) 0.76
[Similar prognosis for transplanted and non-transplanted patients with hematological malignancy admitted to the intensive care unit]. Med Clin (Barc) (2008) 0.76
Cell counter-based parameters and formulas in detection of beta-thalassemia trait. Am J Clin Pathol (2008) 0.75
[Response to rituximab in two patients with plasma exchange-refractory thrombotic thrombocytopenic purpura]. Med Clin (Barc) (2010) 0.75
Flow cytometry for detection of central nervous system disease in acute myeloid leukemia. Leuk Lymphoma (2015) 0.75
[Improvements in the treatment of T-cell acute lymphoblastic leukemia in children]. Med Clin (Barc) (2012) 0.75
[Prognosis of the hematologic patients admitted to an Intensive Care Unit]. Med Clin (Barc) (2012) 0.75
Plerixafor plus G-CSF in combination with chemotherapy for stem cell mobilization in a pediatric patient with Ewing's sarcoma. J Clin Apher (2012) 0.75
Adverse prognosis of bulky disease in good-risk DLBCL. Lancet Oncol (2008) 0.75
Leukaemic vasculitis from myelodysplastic syndrome in context. Lancet (2015) 0.75